Embrace Active Site Care Patch Becomes First Medical Device Clinically Proven to Significantly Improve Lipohypertrophy (LH) in Insulin-Using Diabetes Patients

Findings from 16-week trial of novel compression patch will be shared for the first time at the 85th Scientific Sessions of the American Diabetes Association, beginning today FREMONT, Calif., June 20, 2025 /PRNewswire/ -- Neodyne Biosciences announced that new clinical data demonstrate...

Read More